The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Minireview: Secondary β-Cell Failure in Type 2 Diabetes—A Convergence of Glucotoxicity and Lipotoxicity
Abstract
Chronic hyperglycemia and hyperlipidemia can exert deleterious effects on beta-cell function, respectively referred to as glucotoxicity and lipotoxicity. Over time, both contribute to the progressive deterioration of glucose homeostasis characteristic of type 2 diabetes. The mechanisms of glucotoxicity involve several transcription factors and are, at least in part, mediated by generation of chronic oxidative stress. Lipotoxicity is probably mediated by accumulation of a cytosolic signal derived from the fatty acid esterification pathway. Our view that hyperglycemia is a prerequisite for lipotoxicity is supported by several recent studies performed in our laboratories. First, prolonged in vitro exposure of isolated islets to fatty acids decreases insulin gene expression in the presence of high glucose concentrations only, and glucose is rate-limiting for the incorporation of fatty acids into neutral lipids. Second, normalization of blood glucose in Zucker diabetic fatty rats prevents accumulation of triglycerides and impairment of insulin gene expression in islets, whereas normalization of plasma lipid levels is without effect. Third, high-fat feeding in Goto-Kakizaki rats significantly impairs glucose-induced insulin secretion in vitro, whereas a similar diet has no effect in normoglycemic animals. We propose that chronic hyperglycemia, independent of hyperlipidemia, is toxic for beta-cell function, whereas chronic hyperlipidemia is deleterious only in the context of concomitant hyperglycemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prior studies have linked loss of β-cell identity and dedifferentiation to β-cell dysfunction in models of insulin resistance and reduced islet mass [38, 40].”
In the citing paper
“Islet inflammatory stress increases islet miR-21 expression and is associated with the altered β-cell identity [38].”
Citations
Cites
Pick, A., Clark, J., Kubstrup, C., Levisetti, M., Pugh, W., Bonner-Weir, S., & Polonsky, K. S. (1998) · Diabetes · doi:10.2337/diabetes.47.3.358 · Cited by 551
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 618
NAPDH oxidase mediates glucolipotoxicity-induced beta cell dysfunction – Clinical implications
McCarty, M. F., Barroso-Aranda, J., & Contreras, F. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.09.062 · Cited by 8
Fontès, G., Hagman, D. K., Latour, M. G., Semache, M., & Poitout, V. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.12.020 · Cited by 7
“Chronic hyperglycemia (glucotoxicity) [2], chronic dislipidemia (lipotoxicity) [3], and the association of both (glucolipotoxicity) [4,5], have been proposed to contribute to the”
BackgroundSelf-citationAlssema, M., Schindhelm, R. K., Rijkelijkhuizen, J. M., Kostense, P. J., Teerlink, T., Nijpels, G., Heine, R. J., & Dekker, J. M. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602953 · Cited by 11
“Some observations support the hypothesis that the adverse effects of lipids on insulin secretion only occur in the presence of hyperglycemia, also referred to as glucolipotoxicity (Prentki and Corkey, 1996; Poitout and Robertson, 2002; Robertson et al., 2004).”
BackgroundA case for introducing insulin early in the treatment of type 2 diabetes mellitus
Westphal, S. A., & Palumbo, P. J. (2006) · Insulin · doi:10.1016/s1557-0843(06)80012-6 · Cited by 6
Impact of Apolipoprotein A5 Polymorphisms on Insulin Sensitivity and β-cell Function
Chiu, K. C., Chiu, Y.-F., Boyadjian, A. A., Fernando, S., Kwan, C., & Chuang, L.-M. (2005) · Pancreas · doi:10.1097/01.mpa.0000163176.59920.b1 · Cited by 8
Honey: A Powerful Natural Antioxidant and Its Possible Mechanism of Action
Mushtaq, S., Imtiyaz, Z., Wali, A., Khan, A., Rashid, S., Amin, I., Ali, A., Rehman, M., & Arafah, A. (2020) · doi:10.1007/978-981-15-6799-5_2 · Cited by 8
Understanding Diabetes Mellitus: Pathophysiology
Shah, M., & Vella, A. V. (2015) · Springer eBooks · doi:10.1007/978-1-4939-3220-7_3 · Cited by 11
Altered β-Cell Calcium Dynamics via Electric Field Exposure
Liebman, C., Vu, T.-M., Phillips, A., Chen, B., & Cho, M. (2020) · Annals of Biomedical Engineering · doi:10.1007/s10439-020-02517-w · Cited by 6
Asmar, M., Højberg, P. V., Deacon, C. F., Hare, K. J., Holst, J. J., & Madsbad, S. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.12.004 · Cited by 7
Hiperglicemia pós-prandial: tratamento do seu potencial aterogênico
Geloneze, B., Lamounier, R. N., & Coelho, O. R. (2006) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2006001800018 · Cited by 11
Mechanisms of Beta-Cell Death in Diabetes
Donath, M. Y., & Ehses, J. A. (2008) · Springer eBooks · doi:10.1007/978-4-431-75452-7_5 · Cited by 4
Identification of Effective and Nonpromiscuous Antidiabetic Drug Molecules from Penicillium Species
Saleem, S., Bibi, S., Yousafi, Q., Hassan, T., Khan, M. S., Hasan, M. M., Chopra, H., Moustafa, M., Al-Shehri, M., Khalid, M., et al. (2022) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2022/7040547 · Cited by 6
“1e hallmark of the type 1 and type 2 diabetes is the destruction of pancreatic β-cells [5, 6].”
BackgroundDiaz-Ganete, A., Quiroga-de-Castro, A., Mateos, R., Medina, F., Segundo, C., & Lechuga-Sancho, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052559 · Cited by 6
“and increased levels of free fatty acids (lipotoxicity) associated stresses [5,6].”
BackgroundKohara, K., Obata, A., Kimura, T., Shimoda, M., Moriuchi, S., Okauchi, S., Hirukawa, H., Mune, T., Kaku, K., & Kaneto, H. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0203 · Cited by 5
Preparation of uniformly 13C,15N-labeled recombinant human amylin for solid-state NMR investigation
Kosicka, I., Kristensen, T., Bjerring, M., Thomsen, K., Scavenius, C., Enghild, J. J., & Nielsen, N. C. (2014) · Protein Expression and Purification · doi:10.1016/j.pep.2014.04.002 · Cited by 7
¿Necesitamos nuevos tratamientos para la diabetes tipo 2?
Peralta, F. G., & Padín, C. A. (2014) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2013.10.013 · Cited by 10
Shallangwa, G. A., Abdul-Hamidu, A., Abba, H., Dallatu, Y., & Bilham, D. T. (2013) · doi:10.1080/22311866.2013.866340 · Cited by 6
Silk fibroin hydrolysate ameliorates diabetic dyslipidemia in type 2 diabetic model mice
Park, J. H., Jung, H., Nam, H., Kim, J.-B., Choe, N., & Suh, J. (2013) · doi:10.1080/19768354.2013.839956 · Cited by 6
“These reduced levels of lipid markers are important clinical symptoms because hyperlipidemia is generally associated with pancreatic β-cell malfunction (Zhou & Grill 1994; McGarry & Dobbins 1999; Poitout & Robertson 2002) and induced diabetic cardiovascular disease (Mooradian 2009).”
BackgroundGarris, D. R. (2006) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2006.02.002 · Cited by 6
Baldwin, A. C., Naatz, A., Bohnsack, R., Bartosiak, J. T., Oleson, B. J., Hansen, P., Dahms, N., & Corbett, J. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00680-17 · Cited by 5
Improved antioxidative defence protects insulin-producing cells against homocysteine toxicity
Scullion, S. M., Hahn, C., Tyka, K., Flatt, P. R., McClenaghan, N. H., Lenzen, S., & Gurgul-Convey, E. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.06.019 · Cited by 8
Protective Effect of Propolis Extract on Pancreatic β Cell under Oxidative Stress in vitro
Zagmutt, S., Leiva, E., Mujica, V., & Wehinger, S. (2016) · doi:10.12691/jfnr-4-6-9 · Cited by 5
“However, there are few studies evaluating the protective potential of propolis on the β cell under oxidative stress [36].”
BackgroundHeo, J., Lim, C., Kim, Y., Cho, H.-J., Lee, Y.-D., Maeng, J.-H., Ahn, D., Lee, S., Bang, J., Park, S. Y., et al. (2015) · Chemical Communications · doi:10.1039/c5cc06387f · Cited by 8
Clinical Predictors of Progressive Beta-Cell Failure in Type 2 Diabetes
Irace, C., Tripolino, C., Carallo, C., Scavelli, F. B., Valle, E. D., Cortese, C., & Gnasso, A. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000210 · Cited by 5
Tokunaga, A., Horikawa, Y., Fukuda-Akita, E., Okita, K., Iwahashi, H., Shimomura, I., Takeda, J., & Yamagata, K. (2008) · Endocrine journal · doi:10.1507/endocrj.k08e-083 · Cited by 5
Glitazones: Beyond glucose lowering!
Mankovsky, B., & Kurashvili, R. B. (2007) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2007.06.002 · Cited by 2
Roshanravan, N., Mahdavi, R., Jafarabadi, M. A., Alizadeh, E., Alipour, S., Ghavami, A., Alamdari, N. M., Hedayati, M., Barati, M., Mansoori, B., et al. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.07.019 · Cited by 6
Thuesen, A. C. B., & Vaag, A. A. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13238 · Cited by 5
Weigl, B. H., Zwisler, G., Peck, R. B., & Abu‐Haydar, E. (2013) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2008326 · Cited by 3
Cho, J.-H. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.5.388 · Cited by 4
Pancreatic β-Cell Mass as a Pharmacologic Target in Diabetes
Hanley, S. C. (2020) · McGill Journal of Medicine · doi:10.26443/mjm.v12i2.267 · Cited by 4
Kaneto, H. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.6.701 · Cited by 2
Ruderman, N. B., & Shulman, G. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00043-3 · Cited by 7
Kumar, N. A., & Pari, L. (2006) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.2006.17.1.17 · Cited by 5
Maternal Obesity in Pregnancy: Risk Factor for Neurodevelopmental Outcomes in Offspring
Schmitt, L. O., Faraco, G., Stivanin, T. S., & Gaspar, J. M. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70333 · Cited by 3
“Obesity is associated with elevated circulating levels of glucose and free saturated fatty acids, and the excessive supply of these metabolites can lead to two detrimental conditions known as glucotoxicity and lipotoxicity (Poitout and Robertson 2002).”
Gao, Y.-D., Su, R., Wu, Y., Tie, F., Wang, H.-L., Hu, N., & Dong, Q. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70337 · Cited by 3
Cimbek, E. A., Öztürk, M. A., & Karagüzel, G. (2022) · Turkish Journal of Diabetes and Obesity · doi:10.25048/tudod.1059061 · Cited by 2
Narumi, T., Watanabe, T., Kato, S., Tamura, H., Nishiyama, S., Takahashi, H., Arimoto, T., Shishido, T., & Watanabe, M. (2019) · Circulation Reports · doi:10.1253/circrep.cr-19-0033 · Cited by 4
Sapko, O. A., Tursunova, A., Abaildaev, A. O., Chebonenko, O. V., Krasnoshtanov, A. V., & Utarbaeva, A. S. (2017) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-017-1659-3 · Cited by 3
Effect of Lamium Album on Mitochondrial Oxidative Stress in Diabetic Rats
Khanaki, K., Abedinzade, M., Gazor, R., Norasfard, M., & Jafari-Shakib, R. (2017) · Research in Molecular Medicine · doi:10.29252/rmm.5.2.9 · Cited by 3
Almeida, F. N., Veras, K., Camporez, J., Felitti, V., Chimin, P., Carvalho, C. R., & Paulo-Sp, S. (2013) · doi:10.5171/2013.675769 · Cited by 3
“…in the course of time, the association of glucotoxicity and lipotoxicity promote a failure/destruction of pancreatic β-cells, reducing its mass, and difficulting even more the process of glycaemic control (Eizirik and Cnop, 2010; Guillausseau et al. 2008; Kahn, 2003; Poitout and Robertson, 2002).”
BackgroundLopez-Saura, P., & Herrera-Martínez, B. A.-C. L. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000285 · Cited by 6
“At the end, the decline in peripheral glucose utilization and/ or excessive hepatic production constitutes a major ingredient in the so called insulin resistance whose major consequence is chronic hyperglycemia and/or hyperinsulinemia [16].”
BackgroundTidlig insulinbehandling ved type 2-diabetes?
Birkeland, K. I. (2012) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.12.0866 · Cited by 1
Juang, J., & Kuo, C. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.09.086 · Cited by 3
Someya, Y., Nakano, R., Tahara, A., Takasu, T., Takeuchi, A., Nagase, I., Matsuyama‐Yokono, A., Hayakawa, M., Sasamata, M., Miyata, K., et al. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.024 · Cited by 3
Kim, J., Lee, S., Baik, H., Lee, K., Kim, H., Park, K.-S., & Kim, B.-J. (2008) · Korean Diabetes Journal · doi:10.4093/kdj.2008.32.6.477 · Cited by 3
Goldstein, B. J. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01018.x · Cited by 2
Nouvelles stratégies thérapeutiques dans le diabète de type 2
Halimi, S. (2005) · doi:10.1016/s0755-4982(05)84175-2 · Cited by 3
PDX-1 and MafA: Key Transcription Factors in Pancreas
Kaneto, H., Miyatsuka, T., Nakatani, Y., & Matsuoka, T. (2005) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2005.54.63 · Cited by 3
Using Insulin as a Drug Rather Than as a Replacement Hormone During Acute Illness
Pantaleo, A., & Zonszein, J. (2003) · Heart Disease · doi:10.1097/01.hdx.0000089839.13906.63 · Cited by 3
Effects of Dietary Lipid Intake on Diabetes
Kadegowda, A. K. G., & Yu, L. (2015) · Elsevier eBooks · doi:10.1016/b978-1-78242-247-1.00006-5 · Cited by 5
The Place of Insulin Secretagogues in the Treatment of Type 2 Diabetes in the Twenty-First Century
Stingl, H., & Schernthaner, G. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6_8 · Cited by 4
Oral TIX100 protects against obesity‐associated glucose intolerance and diet‐induced adiposity
Jo, S., Gu, J., Chen, J., Xu, G., & Shalev, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16223 · Cited by 5
“22 TXNIP, in turn, has been shown to be elevated in human and mouse islets with diabetes 8,23 and to promote loss of beta cell function, beta cell apoptosis 7,8,24 and excessive alpha cell glucagon secretion.”
Nonesterified Fatty Acids and Hospitalizations Among Older Adults: The Cardiovascular Health Study
Ahiawodzi, P. D., Bůžková, P., Djoussé, L., Ix, J. H., Kizer, J. R., & Mukamal, K. J. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa228 · Cited by 3
Immunometabolic Associations in Diseases of Complex Genesis
Zemskov, A., Zemskov, V., Luzky, M. A., Popov, S., Pashkov, A., & Zemskova, V. (2020) · Biology Bulletin Reviews · doi:10.1134/s2079086420040118 · Cited by 2
“It is also known that the development of insulin deficiency in type-2 diabetes mellitus is associated with the effect of glucose toxicity and lipotoxicity due to the induction of oxidative stress (Poitout and Robertson, 2002).”
BackgroundInflammation and Type 2 Diabetes
van Greevenbroek, M. M. J., Schalkwijk, C. G., & Stehouwer, C. D. A. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch47 · Cited by 4
elhamid, O. A., Abd-Elsamad, N., & El-Shawarby, R. M. (2015) · Benha Veterinary Medical Journal · doi:10.21608/bvmj.2015.32539 · Cited by 1
“causes destruction of pancreatic -cells and it makes the cells less active to be sensitive enough towards insulin for glucose uptake and this will cause high glucose concentration in blood (Poitout and Robertson, 2002).”
BackgroundMonoacylglycerol as a Metabolic Coupling Factor in Glucose-Stimulated Insulin Secretion
Zhao, S., Iglesias, J., Mugabo, Y., Peyot, M., Joly, E. C., Madiraju, S. R. M., & Prentki, M. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.03.019 · Cited by 2
“…...81 Figure 20 Lipolysis-derived MAG as a MCF for insulin secretion, targeting TRPV1 channels, PKD and Munc13-1…………………………………………..…………………97 xii Liste des abréviations 1-OG 1-oleoylglycerol 1-PG 1-pamitoylglycerol 1-SG 1-stearoylglycerol 2-AG 2-arachidonoyl glycerol 2-OG 2-oleoylglycerol ABHD6 alpha/beta-hydrolase dom…”
BackgroundInfluentialLipid-Induced β-cell Dysfunction And Oxidative Stress
Oprescu, A. I., & Giacca, A. (2007) · Future Lipidology · doi:10.2217/17460875.2.4.455 · Cited by 1
PDX-1 and MafA in β-cell differentiation and dysfunction
Kaneto, H., Miyatsuka, T., Kawamori, D., Shiraiwa, T., Fujitani, Y., & Matsuoka, T. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.5.587 · Cited by 2
Pancreatic Islet Adaptation and Failure in Obesity and Diabetes
Doliba, N. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_27-1 · Cited by 2
Amano, S. U. (2013) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2bw2z · Cited by 1
Glycemic Index, Obesity, and Diabetes
Ebbeling, C. B., & Ludwig, D. S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-400-1_14 · Cited by 2
A Critical Review of Antidiabetic Properties of Tempeh From Various Substrates
Ayustaningwarno, F., Jusman, T. N. G., Afifah, D. N., Asikin, Y., Astawan, M., & Elda, F. (2026) · Journal of Food Science · doi:10.1111/1750-3841.71014 · Cited by 2
Stimulator of interferon genes: A potential target for treating type 2 diabetes mellitus
Ding, X., Wang, W., Wu, J., Li, K., Gao, H., Wu, M., Dong, L., & Xiao, W. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117491
Lutangu, G., Muyangwa-Semenova, M., Omar, R., & Mukololo, L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1618241 · Cited by 1
Tirzépatide, sensibilité et sécrétion d’insuline
Andréelli, F. (2023) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2023.06.005 · Cited by 1
Chou, H., Cheng, K., Lin, A.-C., Hung, H., Lin, C., Wang, C., Wu, H., & Ou, H. (2022) · Pharmaceuticals · doi:10.3390/ph15121569 · Cited by 1
“What is even worse is that chronic hyperglycemia causes glucose toxicity, which leads to beta-cell failure [21].”
BackgroundNourzad, F., Shahidi, F., & pourpour, M. S. (2022) · Journal of Sport and Exercise Physiology · doi:10.52547/joeppa.15.1.69 · Cited by 1
Editorial: What's New in Endocrinology?
Holly, J., & LeRoith, D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00838 · Cited by 1
Sharp, J., Spitters, T., & Vermette, P. (2018) · Biotechnology progress (Print) · doi:10.1002/btpr.2589 · Cited by 1
Close, A.-F. (2017) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r33f4m242
Iwahashi, H., Fukuda-Akita, E., Fukuda-Tokunaga, A., Okita, K., Horikawa, Y., Imagawa, A., Funahashi, T., Shimomura, I., & Yamagata, K. (2011) · Diabetology International · doi:10.1007/s13340-011-0046-7 · Cited by 1
Quantification of the relationship between glycemia and β-cell mass adaptation in vivo
Atkinson, L. L., Topp, B. G., Au, J., Vinerian, H. V., Dhatt, N., & Finegood, D. T. (2009) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y09-044 · Cited by 1
“duced b-cell replication occurring as a secondary consequence of hyperglycemia, dyslipidemia, proinflammatory cytokines, leptin, and islet cell amyloid polypeptides (Marzban et al. 2003; Poitout and Robertson 2002; Unger and Orci 2002; Wajchenberg 2007).”
BackgroundAge-Linked Non-Transmissible Diseases
Swynghedauw, B. (2019) · Practical issues in geriatrics · doi:10.1007/978-3-030-15111-9_6 · Cited by 1
Oxidative Stress in Metabolic Disorders/Diseases
Bansal, M., & Kaushal, N. (2014) · Springer eBooks · doi:10.1007/978-81-322-2032-9_3 · Cited by 1
Significance of Organ Crosstalk in Insulin Resistance and Type 2 Diabetes
Bhatt, S., & Kulkarni, R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-415784-2.00017-8 · Cited by 2
Watve, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4409-1_2 · Cited by 1
The Lipotoxicity and Glucotoxicity Hypothesis in the Metabolic Syndrome and Type 2 Diabetes
Dimitriadis, G., Boutati, E. I., & Raptis, S. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50016-4 · Cited by 2
Physiopathologie des obésités et du diabète de type 2
RABASA-LHORET, R. P. R., & Laville, M. (2004) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(03)00074-x · Cited by 1
Glycogen metabolic dysfunction in T2DM with MASLD: linking α-hydroxybutyrate to GYS2 downregulation
Zhang, Z., Chen, N., Yuan, X., Li, J., & Zhou, W. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1860017
“Therefore, under the dual toxicity of hyperglycemia and hyperlipidemia, molecular pathways associated with the risk of cardiovascular diseases, tumors, and metabolic complications are more likely to be enriched compared to a hyperlipidemic state alone (44–46).”
Choudhari, K., Hiremath, S., Shalavadi, M. H., & Teli, S. (2026) · Hacettepe University Journal of the Faculty of Pharmacy · doi:10.52794/hujpharm.1639845
Kennis, V. C. W., & van Riel, N. A. W. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70722
Pathological Characterization of the Low Doses Alloxan-STZ Diabetic Rabbit Model
Roshan, M. S. M. R., Shafi, O. K. B. M., & Wani, S. M. B. I. (2022) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2022.1102.010
“The changes have been attributed to glucolipotoxicity (Ohno et al., 2000; Merzouk et al., 2000; Poitout and Robertson, 2002; Schmeichel, et al., 2003; El-Said et al., 2010).”
Organic Synthesis with Ligases
Cheng, C. (2022) · Wiley eBooks · doi:10.1002/9781118995167.ch7
Liu, M., Liu, C., Shen, S., Liu, J., & Yin, F. (2020) · Cell Biology International · doi:10.1002/cbin.11350
“Excessive levels of palmitate together with hyperglycemia were synergistic on the dysfunction of islets and cell apoptosis (Briaud et al., 2001; Poitout and Robertson, 2002).”
BackgroundΒ-CELL FAILURE AND PRESERVATION IN TYPE 2 DIABETES MELLITUS: A REVIEW
Singh, K. A., K, B. D. R., & Singh, K. L. (2016) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2016/1204
Development of a computational model of glucose toxicity in the progression of diabetes mellitus
Pérez-Rivera, D. T., Torres-Torres, V. L., Torres-Colón, A. E., & Cruz-Aponte, M. (2016) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2016029 · Cited by 1
Insulin Initiation in Type 2 Diabetes – Why, When and How?
Popa, S. G., Popa, A., & Moța, M. (2016) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.1515/rjdnmd-2016-0011 · Cited by 1
“Consequent deterioration in metabolic equilibrium with increasing levels of glucose and free fatty acids, enhance and accelerate β-cell dysfunction, lead to beta cell apoptosis and subsequent decrease of β-cell mass [10,11].”
BackgroundLong-Term Maintenance of Glucose Control in Veterans with Type 2 Diabetes Mellitus Using Oral Agents
Swislocki, A., Meier, J., Najera, S. M., & Noth, R. H. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0038
Jitrapakdee, S., & Briony, E. (2011) · InTech eBooks · doi:10.5772/21631
“However, chronic exposure of -cells to high concentration of fatty acids promotes -cell apoptosis via the formation of ceramides or other reactive lipids (Giacca et al., 2011; Poitout and Robertson, 2002).”
BackgroundEfek Pemberian Niasin terhadap Glukosa Darah pada Tikus Wistar dengan Obesitas
Hermawan, R., Sitorus, T., & Sastramihardja, H. S. (2011) · Majalah kedokteran Bandung/Majalah Kedokteran Bandung · doi:10.15395/mkb.v43n1.39
Lipid Homeostasis, Chemistry of
Black, P. N., Sealls, W., & Dirusso, C. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb284
Takada, J. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2008.tde-04082008-130026
Hayden, M. R., Karuparthi, P. R., Manrique, C. M., Lastra, G., Habibi, J., & Sowers, J. R. (2017) · Experimental Biology and Medicine · doi:10.3181/00379727-232-2320772 · Cited by 2
Nutrition Support and Hyperglycemia
Brett, E. M. (2006) · doi:10.1201/9781420014884-11
Metadata
- Authors
- Poitout, V., & Robertson, R. P.
- Affiliations
- University of Washington (US)
- Corresponding author
- Poitout, Vincent
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2002-02
- Volume
- 143
- Issue
- 2
- Pages
- 339-342
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W1971701221
- Cited by
- 743
- References
- 0
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 9 · 2023: 11 · 2022: 13 · 2021: 24 · 2020: 23 · 2019: 16 · 2018: 22 · 2017: 24 · 2016: 20 · 2015: 49 · 2014: 41 · 2013: 41 · 2012: 45
- FWCI
- 37.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R-01-DK-38325, R01 DK 58096)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- type 2 diabetes, beta-cell dysfunction, glucotoxicity, lipotoxicity, hyperglycemia, hyperlipidemia, oxidative stress, transcription factors, fatty acid esterification, insulin gene expression, glucose-stimulated insulin secretion, triglyceride accumulation, high-fat diet, islets
- MeSH terms
- Animals, Chronic Disease, Diabetes Mellitus, Type 2, Humans, Hyperglycemia, Hyperlipidemias, Islets of Langerhans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review